Eyenovia announces presentation at the octane ophthalmology tech forum 2023

Presentation to highlight recent fda approval of mydcombi™ for mydriasis which leverages eyenovia's novel optejet dispensing device
EYEN Ratings Summary
EYEN Quant Ranking